Majority of younger patients dying of cancer use aggressive interventions in last month of life
the ONA take:
According to a recent study published in JAMA Oncology, researchers at Dana-Farber Cancer Institute/Boston Children's Cancer and Blood Disorders Center and Kaiser Permanente Southern California have found that more than two-thirds of adolescents and young adults dying as a result of cancer underwent at least one aggressive intervention during the last month of life.
For the study, researchers evaluated the use of intensive care, the emergency room, chemotherapy, and/or hospitalization in the last month of life in 633 patients aged 15 to 39 years who died of cancer between 2001 and 2010.
Results showed that young patients were more than two times as likely as patients 65 and older to receive intensive care and/or use the emergency room during the last month of life. The rate of use of chemotherapy and hospitalization was similar among both age groups. Researchers found that 22% of the adolescents and young adults used intensive care and/or the emergency room in the last month of life, 11% received chemotherapy in the last two weeks of life, and 62% were hospitalized in the last month of life.
The findings suggest that further research is warranted to determine whether younger patients dying of cancer have been adequately supported to make their end-of-life decisions.
More than two-thirds of adolescents and young adults dying as a result of cancer underwent at least one aggressive intervention during the last month of life.
- Acupuncture an Effective Alternative Treatment for Cancer-Related Fatigue
- Response to Anemia Treatment Differs in Lymphoma, Multiple Myeloma
- Compound in Teas, Peas, Soybeans May Increases Prostate Cancer Risk
- Fertility Preservation in Male Adolescents and Young Adults With Cancer
- Social, Psychiatric Variables Reduce Cognitive Functioning, QoL in HNC
- HPV and Cancer (Fact Sheet)
- Pain Control More Easily Achieved With Nurse-Led Education in Bone Metastases
- Using Nutrition-Based Strategies to Manage Adverse Effects of Cancer
- Palliative Care Associated With Decreased Costs For Patients With Advanced Cancer
- A Case of Immunotherapy-Induced Myocarditis Concomitant to MG in Lung Cancer
- Online Learning Modules Improve Exercise Counseling, But Not Participation
- ASCO Issues Statement Addressing Alcohol and Cancer
- Duloxetine May Improve AI-Associated Joint Pain in Early Stage Breast Cancer
- Axillary Lymph Node Dissection Predictive for Lymphedema in Breast Cancer
- Drug Combination Does Not Extend Glioblastoma Survival
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|